Note: This version of section effective until 7-1-2019. See also following version of this section, effective 7-1-2019.
Sec. 8. (a) A prescriber may issue a prescription to a patient who is receiving services through the use of telemedicine if the patient has not been examined previously by the prescriber in person if the following conditions are met:
(1) The prescriber has satisfied the applicable standard of care in the treatment of the patient.
(2) The issuance of the prescription by the prescriber is within the prescriber's scope of practice and certification.
(3) The prescription:
(A) meets the requirements of subsection (b); and
(B) is not for an opioid. However, an opioid may be prescribed if the opioid is a partial agonist that is used to treat or manage opioid dependence.
(4) The prescription is not for an abortion inducing drug (as defined in IC 16-18-2-1.6).
(5) The prescription is not for an ophthalmic device, including:
(A) glasses;
(B) contact lenses; or
(C) low vision devices.
(b) Except as provided in subsection (a), a prescriber may issue a prescription for a controlled substance (as defined in IC 35-48-1-9) to a patient who is receiving services through the use of telemedicine, even if the patient has not been examined previously by the prescriber in person, if the following conditions are met:
(1) The prescriber maintains a valid controlled substance registration under IC 35-48-3.
(2) The prescriber meets the conditions set forth in 21 U.S.C. 829 et seq.
(3) The patient has been examined in person by a licensed Indiana health care provider and the licensed health care provider has established a treatment plan to assist the prescriber in the diagnosis of the patient.
(4) The prescriber has reviewed and approved the treatment plan described in subdivision (3) and is prescribing for the patient pursuant to the treatment plan.
(5) The prescriber complies with the requirements of the INSPECT program (IC 25-26-24).
(c) A prescription for a controlled substance under this section must be prescribed and dispensed in accordance with IC 25-26-24.
As added by P.L.78-2016, SEC.2. Amended by P.L.150-2017, SEC.7; P.L.51-2019, SEC.3.
Note: This version of section effective 7-1-2019. See also preceding version of this section, effective until 7-1-2019.
Sec. 8. (a) A prescriber may issue a prescription to a patient who is receiving services through the use of telemedicine if the patient has not been examined previously by the prescriber in person if the following conditions are met:
(1) The prescriber has satisfied the applicable standard of care in the treatment of the patient.
(2) The issuance of the prescription by the prescriber is within the prescriber's scope of practice and certification.
(3) The prescription:
(A) meets the requirements of subsection (b); and
(B) is not for an opioid. However, an opioid may be prescribed if the opioid is a partial agonist that is used to treat or manage opioid dependence.
(4) The prescription is not for an abortion inducing drug (as defined in IC 16-18-2-1.6).
(5) The prescription is not for an ophthalmic device, including:
(A) glasses;
(B) contact lenses; or
(C) low vision devices.
(b) Except as provided in subsection (a), a prescriber may issue a prescription for a controlled substance (as defined in IC 35-48-1-9) to a patient who is receiving services through the use of telemedicine, even if the patient has not been examined previously by the prescriber in person, if the following conditions are met:
(1) The prescriber maintains a valid controlled substance registration under IC 35-48-3.
(2) The prescriber meets the conditions set forth in 21 U.S.C. 829 et seq.
(3) The patient has been examined in person by a licensed Indiana health care provider and the licensed health care provider has established a treatment plan to assist the prescriber in the diagnosis of the patient.
(4) The prescriber has reviewed and approved the treatment plan described in subdivision (3) and is prescribing for the patient pursuant to the treatment plan.
(5) The prescriber complies with the requirements of the INSPECT program (IC 25-26-24).
(c) A prescription for a controlled substance under this section must be prescribed and dispensed in accordance with IC 25-1-9.3 and IC 25-26-24.
As added by P.L.78-2016, SEC.2. Amended by P.L.150-2017, SEC.7; P.L.51-2019, SEC.3; P.L.28-2019, SEC.10; P.L.211-2019, SEC.34.
Copyright ©2024 LegalFix. All rights reserved. LegalFix is not a law firm, is not licensed to practice law, and does not provide legal advice, services, or representation. The information on this website is an overview of the legal plans you can purchase—or that may be provided by your employer as an employee benefit or by your credit union or other membership group as a membership benefit.
LegalFix provides its members with easy access to affordable legal services through a network of independent law firms. LegalFix, its corporate entity, and its officers, directors, employees, agents, and contractors do not provide legal advice, services, or representation—directly or indirectly.
The articles and information on the site are not legal advice and should not be relied upon—they are for information purposes only. You should become a LegalFix member to get legal services from one of our network law firms.
You should not disclose confidential or potentially incriminating information to LegalFix—you should only communicate such information to your network law firm.
The benefits and legal services described in the LegalFix legal plans are not always available in all states or with all plans. See the legal plan Benefit Overview and the more comprehensive legal plan contract during checkout for coverage details in your state.
Use of this website, the purchase of legal plans, and access to the LegalFix networks of law firms are subject to the LegalFix Terms of Service and Privacy Policy.